Humacyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Humacyte using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $-0.11 | $-0.16 | 31.3 % |
| Q2 | 2025-08-11 | $-0.24 | $-0.17 | -41.2 % |
| Q1 | 2025-05-13 | $-0.10 | $-0.19 | 47.4 % |
| Q4 | 2025-03-28 | $-0.16 | $-0.25 | 36.0 % |
Humacyte (HUMA) is scheduled to report earnings on March 27, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.
The Actual EPS was $-0.11, which beat the estimate of $-0.16.
The Actual Revenue was $753.00K, which missed the estimate of $921.70K.
Browse earnings estimates, EPS, and revenue on all stocks.
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $753.00K | $921.70K | -18.3 % |
| Q2 | 2025-08-11 | $301.00K | $1.06M | -71.5 % |
| Q1 | 2025-05-13 | $517.00K | $530.00K | -2.45 % |
| Q1 | 2024-05-10 | $0 | $20.00K | -100.0 % |